Thus, careful monitoring during the first weeks of GLP-1 therapy is critical
It still releases growth hormone in pulses rather than constant elevated levels
We aim to keep product information accurate and up to date, but manufacturer information may change
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward (5 mg, 7.5 mg, 10 mg, 12.5 mg, to a maximum of 15 mg) based on therapeutic response and tolerability
If things don't improve, or you're dealing with regular nausea, vomiting, or reflux, it's worth talking to your dentist or your prescribing provider
Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials